The news of a coronavirus (COVID-19) vaccine has been widely welcomed. However, those with blood cancer - considered to amongst the most clinically extremely vulnerable – may have particular questions about the safety and effectiveness of the vaccine, and its availability for them.
This webinar aims to give information, guidance and reassurance to people living with blood cancer around the COVID-19 vaccine. This includes the different types of vaccines in use and development, their mode of action and suitability for people with blood cancer, and details of the roll-out of the vaccine over the coming weeks and months.
In our live webinar we will be joined by a panel of three UK lymphoma experts, who will be addressing your questions about the vaccines:
- Dr Graham Collins, Haematology Consultant, Oxford University Hospitals
- Dr Wendy Osborne, Consultant Haematologist, Freeman Hospital, Newcastle upon Tyne
- Dr Robert Marcus, Consultant Haematologist, HCA Healthcare, London
- Dr Shirley Hopper, Medical Assessor, MHRA
This webinar is for anyone affected by lymphoma or leukaemia in the UK.
Joining the webinar
This webinar is run through GoToWebinar. If you haven't used GoToWebinar before, you might like to join the webinar a few minutes early to ensure you can get connected. (Some devices might require you to download the GoToWebinar app to run the webinar.)
Please note: once you register on GoToWebinar you will be sent a unique joining link, and this will come from GoToWebinar directly (if you don't receive it, please check your email spam box!) You will also receive a reminder one day before, and one hour before, the webinar.